Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07228026 · ClinicalTrials.gov registry record

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

A clinical trial of Asthma, sponsored by Biometry.

Recruiting
Registry status
160
Enrollment target
13
Study locations

NCT07228026 is a study of Asthma that is actively recruiting participants, run by Biometry. The registered enrollment target is 160 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (90% lower). The trial reports 13 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07228026, a study of Asthma, is actively recruiting participants, sponsored by Biometry.

RECRUITING
Registry status
160 participants
Enrollment target
13
Study locations

Study Summary

This study incorporates objectives directed at two subject cohorts: 1. Uncontrolled Adult and Pediatric Asthma Subjects: To demonstrate a statistically significant and clinically meaningful decline in Point Of Care (POC) FeNO as measured by the fenoTRACK device, after an approximately 2-week course of corticosteroid therapy in adults and children with non-steroid treated uncontrolled asthma. 2. Controlled Adult and Pediatric Asthma Subjects: * To evaluate within-session clinical precision during Visit 1 and Visit 2 for the fenoTRACK device for simulated at home FeNO, and at POC * To evaluate within-session clinical precision for home fenoTRACK use

Conditions Studied

Asthma

Interventions

  • DEVICE fenoTRACK Device

Study Locations (13)

Texas

  • Orion Clinical Research - Austin
  • Pharmaceutical Research & Consulting, Inc. - Dallas
  • Western Sky Medical Research - El Paso

Maryland

  • AllerVie Clinical Research - Ellicott City
  • AllerVie Clinical Research - Glenn Dale

California

  • Bensch Clinical Research LLC - Stockton

Florida

  • AllerVie Clinical Research - Panama City

Georgia

  • AllerVie Clinical Research - Columbus

Maine

  • Paul A Shapero MD - Bangor

Nebraska

  • Nebraska Medical Research Institute, Inc. - Bellevue

North Carolina

  • Allergy Partners Clinical Research - Asheville

Trial Details

FieldValue
Enrollment Target 160 participants
Start Date 2025-09-17
Est. Completion 2026-09-30

Sponsor

Biometry

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07228026

The ClinicalTrials.gov registry entry for NCT07228026 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 160 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (90% lower). The listed sponsor is Biometry, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which fenoTRACK Device is the first listed.

NCT07228026 reports 13 study locations spanning 10 distinct geographic areas - top geographies include Texas, Maryland, California.

Frequently Asked Questions

What is clinical trial NCT07228026 about?

NCT07228026 is a clinical study titled "Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects". This study incorporates objectives directed at two subject cohorts: 1. Uncontrolled Adult and Pediatric Asthma Subjects: To demonstrate a statistically significant and clinically meaningful decline in Point Of Care (POC) FeNO as measured by the fenoTRACK device, after an approximately 2-week course...

What is the current status of trial NCT07228026?

This trial is currently recruiting. The enrollment target is 160 participants. The study started on 2025-09-17. Estimated completion is 2026-09-30.

What conditions does trial NCT07228026 study?

This clinical trial studies the following conditions: Asthma.

What interventions are being tested in trial NCT07228026?

The interventions under investigation include: fenoTRACK Device (DEVICE).

Who is sponsoring clinical trial NCT07228026?

This trial is sponsored by Biometry, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07228026 being conducted?

This trial has 13 study locations across California, Florida, Georgia, Maine, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Asthma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Asthma

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.